Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-017-3372-z
Abstract: PurposeManganese porphyrins are redox-active drugs and superoxide dismutase mimics, which have been shown to chemosensitize lymphoma, a cancer which frequently occurs in dogs. This study aimed to identify critical information regarding the pharmacokinetics and toxicity… read more here.
Keywords: lymphoma; lymph nodes; drug; canine lymphoma ... See more keywords
Procarbazine, prednisolone and cyclophosphamide (PPC) oral combination chemotherapy protocol for canine lymphoma.
Sign Up to like & getrecommendations! Published in 2022 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12814
Abstract: Orally administered daily chemotherapy offers a novel treatment approach for canine lymphoma in a population of dogs that have failed or not tolerated maximum tolerable dose chemotherapy. A multidrug oral chemotherapy protocol was designed and… read more here.
Keywords: chemotherapy protocol; canine lymphoma; procarbazine prednisolone; protocol ... See more keywords
Evaluation of serum interleukin 2 receptor and beta-2-microglobulin as prognostic factors for canine lymphoma: a pilot study.
Sign Up to like & getrecommendations! Published in 2023 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12873
Abstract: Interleukin 2 receptor (IL-2R) is released from activated T cell lymphocytes and related to proliferation of B cells and T cells. Beta-2-microglobulin (B2M) is synthesized from all nucleated cells and constitutes a major histocompatibility complex… read more here.
Keywords: b2m; lymphoma; serum; canine lymphoma ... See more keywords
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Sign Up to like & getrecommendations! Published in 2023 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12913
Abstract: Multi-agent chemotherapy successfully induces remission in most naïve, high-grade canine lymphoma patients; however, disease recurrence is common. MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) is an effective rescue protocol used to re-induce remission, but is associated… read more here.
Keywords: canine lymphoma; procarbazine prednisone; lymphoma; mechlorethamine ... See more keywords
MUM-1 in canine lymphoma: A pilot study
Sign Up to like & getrecommendations! Published in 2023 at "Veterinary Pathology"
DOI: 10.1177/03009858231155401
Abstract: Expression of interferon regulatory factor 4 (IRF4)/multiple myeloma oncogene-1 (MUM1) in peripheral T-cell lymphoma (PTCL) in people is associated with a poorer survival outcome compared to cases of PTCL lacking MUM1 expression. The aim of… read more here.
Keywords: lymphoma; cell lymphoma; canine; canine lymphoma ... See more keywords
Markers of inflammation and fibrinolysis in canine lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "Veterinarski arhiv"
DOI: 10.24099/vet.arhiv.0489
Abstract: Canine lymphoma is one of the most common haematological neoplasms. Results of a numerous studies indicate the important role of chronic inflammation in the development of cancer. The aim of this study was to determine… read more here.
Keywords: lymphoma; markers inflammation; group; canine lymphoma ... See more keywords
Review of Canine Lymphoma Treated with Chemotherapy—Outcomes and Prognostic Factors
Sign Up to like & getrecommendations! Published in 2023 at "Veterinary Sciences"
DOI: 10.3390/vetsci10050342
Abstract: Simple Summary Canine lymphoma is a common cancer of one of the white blood cells that is commonly treated with chemotherapy. Many papers have been published about this disease and treatment, but few comprehensive reviews… read more here.
Keywords: review canine; prognostic factors; canine lymphoma; treated chemotherapy ... See more keywords